Terminated NCT03121586
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Phoenix Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. Over 18 Years
Countries United States, Canada, Argentina, ...
Sponsor ACADIA Pharmaceuticals Inc.
Condition Schizophrenia Completed NCT02600741
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Bullhead City Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries United States
Sponsor Janssen Scientific Affairs, LLC
Condition Schizophrenia Completed NCT00304473
This summary needs review. Please check the official study record and contact the research team for details.
In Taoyuan Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries Taiwan
Sponsor AstraZeneca
Condition Schizophrenia Completed NCT00254813
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Arendal Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 60 Years
Countries Norway
Sponsor AstraZeneca
Condition Schizophrenia Terminated NCT01568203
This study was terminated in the United States. It is testing AMG 579 for schizophrenia.
In Glendale Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 60 Years
Countries United States
Sponsor Amgen
Condition Schizophrenia Completed NCT01190254
This study is completed. It is testing asenapine for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 12 Years to 17 Years
Countries
Sponsor Organon and Co
Condition Schizophrenia Completed NCT01190267
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 12 Years to 17 Years
Countries
Sponsor Organon and Co
Condition Schizophrenia Completed NCT06036108
This summary needs review. Please check the official study record and contact the research team for details.
In Saga Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 64 Years
Countries Japan
Sponsor Otsuka Pharmaceutical Co., Ltd.
Condition Schizophrenia Terminated NCT03040505
This summary needs review. Please check the official study record and contact the research team for details.
In Strasbourg Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Observational i A study where researchers collect information without assigning a treatment. From 18 Years to 55 Years
Countries France
Sponsor University Hospital, Strasbourg, France
Condition Schizophrenia Completed NCT05258123
This summary needs review. Please check the official study record and contact the research team for details.
In Beijing Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 60 Years
Countries China
Sponsor Beijing HuiLongGuan Hospital
Condition Schizophrenia Completed NCT01569659
This summary needs review. Please check the official study record and contact the research team for details.
In Chicago Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 60 Years
Countries United States
Sponsor Northwestern University
Condition Schizophrenia Completed NCT01022489
This study is completed in France. It is testing high Frequency Repetitive Transcranial Magnetic Stimulation for schizophrenia.
In Caen Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Device i A study involving a tool, app, wearable, test, or medical device. From 16 Years to 65 Years
Countries France
Sponsor University Hospital, Caen
Condition Schizophrenia